Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

417 trials

2026-525267-40-00
Recruiting
Intensified Monitoring of PhArmacology of Cabozantinib as a tool for Toxicity management in patients with renal cell carcinoma
Phase 4 · Italy · 2 sites
Registry update: 21 May 2026
NCT07749586
Recruiting
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Phase 1/2 · United States · 4 sites
Registry update: 13 Oct 2026
NCT07680556
Recruiting
Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma
Not applicable · Netherlands · 2 sites
Registry update: 28 Aug 2026
NCT07594106
Recruiting
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
Phase 1/2 · United States · 6 sites
Registry update: 28 Sept 2026
NCT07636785
Recruiting
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
Phase 1/2 · United States · 2 sites
Registry update: 3 Nov 2026
2024-517098-26-00
Recruiting
Multicentric study evaluating the usefulness of early PSMA PET scan in metastatic renal cancer requiring standard immunotherapy treatment.
Phase 2 · Belgium · 3 sites
Registry update: 13 Feb 2026
NCT07875959
Recruiting
18F-N230A PET/CT Imaging of Nectin-4 Expression in Renal Tumors
Not applicable · China · 1 site
Registry update: 15 Oct 2026
NCT07037004
Recruiting
Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery
Phase 2 · United States · 2 sites
Registry update: 19 Oct 2026
NCT07688187
Recruiting
A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma
Phase 1 · United States · 1 site
Registry update: 18 Sept 2026
NCT07564232
Recruiting
Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma
Phase 1 · United States · 1 site
Registry update: 9 Oct 2026
NCT07636148
Recruiting
Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
Not applicable · France, Netherlands · 3 sites
Registry update: 1 Sept 2026
NCT07645690
Recruiting
The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma
Early phase 1 · China · 2 sites
Registry update: 22 Jun 2026
NCT07647744
Recruiting
To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer
Phase 1 · China · 1 site
Registry update: 2 Jul 2026
NCT07615348
Recruiting
CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk
Phase 2 · China · 5 sites
Registry update: 11 Aug 2026
NCT07671417
Recruiting
Imaging Study in Metastatic Clear Cell RCC.
Early phase 1 · Australia, New Zealand, South Africa · 6 sites
Registry update: 13 Oct 2026
NCT06770855
Recruiting
Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)
Not applicable · United States · 1 site
Registry update: 8 Oct 2026
NCT07623369
Recruiting
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
Phase 1 · Australia, China · 3 sites
Registry update: 21 Aug 2026
NCT07043608
Recruiting
Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
Phase 2 · United States · 1 site
Registry update: 27 Jul 2026
NCT07646847
Recruiting
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Not applicable · United States · 8 sites
Registry update: 28 Oct 2026
NCT07383441
Recruiting
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
Phase 3 · United States · 41 sites
Registry update: 11 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.